Thomas Pålsson
Director of Finance/CFO at CIRCHEM AB
Network origin in Thomas Pålsson first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
11
| Public Company | Chemicals: Major Diversified | 11 |
| Public Company | Pharmaceuticals: Major | 11 | |
| Public Company | Biotechnology | 10 | |
| Public Company | Medical Specialties | 8 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Thomas Pålsson via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
HemoCue AB
 HemoCue AB Medical SpecialtiesHealth Technology HemoCue AB develops, produces, and markets medical diagnostic products for point of care testing. Its solutions include hematology, diabetes, data management and connectivity solutions, and accessories and consumables. The company was founded in 1982 and is heaquartered in Angelholm, Sweden. | Medical Specialties | Sales & Marketing Corporate Officer/Principal | |
| Karolinska Institutet | College/University | Doctorate Degree Doctorate Degree Doctorate Degree | |
| Chalmers University of Technology | College/University | Graduate Degree Graduate Degree Graduate Degree | |
| Stockholm School of Economics | College/University | Masters Business Admin Graduate Degree | |
| University of Uppsala | College/University | Graduate Degree Masters Business Admin Graduate Degree | |
Arexis AB
 Arexis AB Pharmaceuticals: MajorHealth Technology Arexis AB develops and manufactures pharmaceutical products. Its products are used for molecular dissection of metabolic and inflammatory diseases. The company was founded in 1999 and is headquartered in Goteborg, Sweden. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Founder | |
| University of Stockholm | College/University | Undergraduate Degree Undergraduate Degree | |
| University of Lund | College/University | Undergraduate Degree Masters Business Admin Doctorate Degree | |
| VIVESTO AB | Pharmaceuticals: Generic | Chief Executive Officer | |
Perstorp Holding AB
 Perstorp Holding AB Chemicals: Major DiversifiedProcess Industries Perstorp Holding AB engages in the development, manufacture and sale of specialty chemicals. It operates through the Specialties and Solutions, and Advanced Chemicals and Derivatives segments. The Specialties and Solutions segment consists of the business units, Feed and Food, and Specialty Polyols. The Advanced Chemicals and Derivatives segment includes the business units Penta, Oxo, TMP and Neo, and Formates. The company was founded by Wilhelm Wendt in 1881 and is headquartered in Malmo, Sweden. | Chemicals: Major Diversified | Corporate Officer/Principal | |
| NIMUTAN AB (PUBL) | Household/Personal Care | Director/Board Member | |
| University of Gothenburg | College/University | Doctorate Degree Undergraduate Degree Undergraduate Degree Doctorate Degree Undergraduate Degree | |
| IHM Business School AB | College/University | Undergraduate Degree | |
| Faculty of Engineering, Lund University | College/University | Graduate Degree Graduate Degree | |
Aprea Therapeutics AB
 Aprea Therapeutics AB Pharmaceuticals: MajorHealth Technology Aprea Therapeutics AB operates as a holding company that provides research performed at Karolinska Institutet. It focuses its activities on discovery and development of novel anticancer compounds targeting the tumor suppressor protein. Its product has been tested in a Phase I/II dose escalating safety study in patients with refractory hematological malignancies or prostate carcinoma. It pursues the development of an anticancer drug, APR-246, which has p53-based mechanism for patients with ovarian cancer. The company was founded by Klas Gosta Wiman, Galina Selivanova, Vladimir Bykov, Wenjie Bao, Natalia Issaeva, and Staffan Strömblad in 2003 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Chief Executive Officer | |
| WNTRESEARCH AB | Pharmaceuticals: Other | Chairman Director/Board Member | |
Eton Systems AB
 Eton Systems AB Industrial MachineryProducer Manufacturing Eton Systems AB engages in manufacturing lifting and handling equipment. It offers solution fitted sheet, solution car seat, solution quilts, solutions shirt and solution jeans services. The company was founded in 1967 and is headquartered in Ganghester, Sweden. | Industrial Machinery | Chief Executive Officer | |
ProNoxis AB
 ProNoxis AB Pharmaceuticals: MajorHealth Technology ProNoxis AB develops small-molecule drugs to treat chronic inflammation. The company was founded in 2009 and is headquartered in Lund, Sweden. | Pharmaceuticals: Major | Director/Board Member | |
| OxyPharma AB | Chief Executive Officer | ||
| SPRINT BIOSCIENCE AB | Pharmaceuticals: Major | Chief Executive Officer | |
TikoMed AB
 TikoMed AB Pharmaceuticals: MajorHealth Technology TikoMed AB is a Swedish pharmaceutical company that develops pharmaceutical products. The private company is based in Viken, Sweden. The company was founded by Adam Bruce, Lars Bruce. Anders Kristensson has been the CEO of the company since 2018. | Pharmaceuticals: Major | Director/Board Member | |
| AstraZeneca R&D Mölndal | Corporate Officer/Principal Corporate Officer/Principal | ||
| BIO VITOS PHARMA AB | Medical Specialties | Chief Executive Officer Director/Board Member | |
| Westminster Business School | College/University | Undergraduate Degree | |
Aptahem AB
 Aptahem AB Pharmaceuticals: MajorHealth Technology Aptahem AB operates as a biotechnology company. The firm engages in developing drug candidates for the treatment and prevention of disease caused by blockages in blood vessels as the result of blood clots, such as deep vein thrombosis, stroke and heart failure. Its main business model is to clinically develop aptamer-based treatments for life-threatening acute conditions where coagulation and inflammation interact in the disease process. The company was founded byLuiza Jedlina, Bert Junno, Tina Persson and Johan Lindh in 2014 and is headquartered in Malmo, Sweden. | Pharmaceuticals: Major | Chief Operating Officer | |
| Nexam Chemical AB | Chairman | ||
| CERENO SCIENTIFIC AB | Pharmaceuticals: Major | Chairman | |
| REDWOOD PHARMA AB | Pharmaceuticals: Major | Chairman | |
| Stayble AB | Director/Board Member | ||
| LIPUM AB | Biotechnology | Chairman | |
| Ub-Consulting AB | Chief Executive Officer | ||
| ISR IMMUNE SYSTEM REGULATION HOLDING AB (PUBL) | Pharmaceuticals: Major | Director/Board Member | |
| ANNEXIN PHARMACEUTICALS AB | Pharmaceuticals: Major | Director/Board Member | |
| LIFECLEAN INTERNATIONAL AB | Miscellaneous Commercial Services | Director/Board Member | |
| ZICCUM AB | Medical Specialties | Chairman Director/Board Member | |
| Hemmeslöv Förvaltning AB | Chairman | ||
| Hemmeslöv Consulting AB | Director/Board Member | ||
| Synartro AB | Chief Tech/Sci/R&D Officer | ||
| Green Seedtech AB | Director/Board Member | ||
Nexam Performance Masterbatch AB
 Nexam Performance Masterbatch AB Chemicals: SpecialtyProcess Industries Nexam Performance Masterbatch AB is a Swedish company that specializes in manufacturing and supplying color concentrate additives for the plastics industry. | Chemicals: Specialty | Chairman | |
| Plasticolor Forvaltnings AB | Chairman | ||
| Fibonacci Vind Sverig AB | Chairman | ||
Designed Chemistry AB
 Designed Chemistry AB Chemicals: Major DiversifiedProcess Industries Designed Chemistry AB specializes in the development of polyolefin catalysts for various reactor types. The Swedish company's laboratory is equipped with advanced technology to continuously improve their catalysts, including the Enhanced Polyolefin Catalysts (EPOC). The private company's proprietary technology allows for the customization of catalyst recipes to meet the specific requirements of each customer. Designed Chemistry also has advanced research and development capabilities to create catalysts with superior processing performance. | Chemicals: Major Diversified | Corporate Officer/Principal Director/Board Member | |
| Stockholm Academy AB | Chairman | ||
| Saratov Holding AB | Chief Executive Officer | ||
| BIOEXTRAX AB | Biotechnology | Chairman |
Statistics
International
| Sweden | 50 |
| United Kingdom | 2 |
Sectoral
| Health Technology | 19 |
| Consumer Services | 11 |
| Commercial Services | 4 |
| Process Industries | 4 |
| Consumer Non-Durables | 2 |
Operational
| Director/Board Member | 140 |
| Chairman | 50 |
| Corporate Officer/Principal | 38 |
| Chief Executive Officer | 36 |
| Independent Dir/Board Member | 28 |
Most connected contacts
| Insiders | |
|---|---|
| Thomas Bengt Eldered | 41 |
| Per Gunnar Fernström | 21 |
| Clas Runnberg | 15 |
| Erik Kinnman | 14 |
| Ulf Björklund | 14 |
| Mats Persson | 13 |
| Karl Fredrik Sjövall | 13 |
| Vidar Wendel-Hansen | 13 |
| Petra Sas | 12 |
| Eva Lindgren | 10 |
| Björn Löwenadler | 9 |
| Carl Jonas Stålhandske | 9 |
| Mattias Münnich | 9 |
| Christina Hillforth | 8 |
| Karin Cecilia Dahllöf | 8 |
- Stock Market
- Insiders
- Thomas Pålsson
- Company connections
